Akebia Therapeutics Stock Price To Book
| AX9 Stock | 1.93 0.02 1.05% |
Akebia Therapeutics fundamentals help investors to digest information that contributes to Akebia Therapeutics' financial success or failures. It also enables traders to predict the movement of Akebia Stock. The fundamental analysis module provides a way to measure Akebia Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Akebia Therapeutics stock.
Akebia |
Akebia Therapeutics Company Price To Book Analysis
Akebia Therapeutics' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Akebia Therapeutics Price To Book | 3.97 X |
Most of Akebia Therapeutics' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Akebia Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Akebia Therapeutics has a Price To Book of 3.9674 times. This is much higher than that of the sector and significantly higher than that of the Price To Book industry. The price to book for all Germany stocks is notably lower than that of the firm.
Akebia Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Akebia Therapeutics' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Akebia Therapeutics could also be used in its relative valuation, which is a method of valuing Akebia Therapeutics by comparing valuation metrics of similar companies.Akebia Therapeutics is currently under evaluation in price to book category among its peers.
Akebia Fundamentals
| Current Valuation | 12.46 M | |||
| Price To Book | 3.97 X | |||
| Price To Sales | 0.18 X | |||
| Revenue | 213.58 M | |||
| EBITDA | (227.35 M) | |||
| Net Income | (282.84 M) | |||
| Cash Flow From Operations | (252.97 M) | |||
| Market Capitalization | 387.3 M | |||
| Total Asset | 525.55 M | |||
| Net Asset | 525.55 M |
About Akebia Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Akebia Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Akebia Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Akebia Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Akebia Stock Analysis
When running Akebia Therapeutics' price analysis, check to measure Akebia Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Therapeutics is operating at the current time. Most of Akebia Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akebia Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Therapeutics' price. Additionally, you may evaluate how the addition of Akebia Therapeutics to your portfolios can decrease your overall portfolio volatility.